(Q46503090)

22 December 2017

title

Improvement in psoriasis with rosiglitazone in a diabetic and a nondiabetic patient (English)

1 reference

22 December 2017

1 reference

Harrihar A Pershadsingh

series ordinal

1

1 reference

22 December 2017

Steven C Benson

series ordinal

2

1 reference

22 December 2017

Charles N Ellis

series ordinal

3

1 reference

22 December 2017

publication date

1 November 2005

1 reference

22 December 2017

published in

Skinmed

1 reference

22 December 2017

volume

4

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

386-390

1 reference

22 December 2017

Peroxisome proliferator-activated receptor gamma and metabolic disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Simplified method for determination of rosiglitazone in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

Peroxisome proliferator-activated receptors as new molecular targets in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2005.04434.X

10.1111/J.1540-9740.2005.04434.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017